These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9248618)

  • 21. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin.
    Takematsu H; Tagami H
    Arch Dermatol; 1993 Jan; 129(1):74-80. PubMed ID: 8420495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 and interleukin-6 in psoriasis.
    Prens EP; Benne K; van Damme J; Bakkus M; Brakel K; Benner R; van Joost T
    J Invest Dermatol; 1990 Dec; 95(6 Suppl):121S-124S. PubMed ID: 2258628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA, DNA, and cell surface characteristics of lesional and nonlesional psoriatic skin.
    Staiano-Coico L; Gottlieb AB; Barazani L; Carter DM
    J Invest Dermatol; 1987 May; 88(5):646-51. PubMed ID: 2437219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of interleukin-12 is increased in psoriatic skin.
    Yawalkar N; Karlen S; Hunger R; Brand CU; Braathen LR
    J Invest Dermatol; 1998 Dec; 111(6):1053-7. PubMed ID: 9856816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production.
    Teng X; Hu Z; Wei X; Wang Z; Guan T; Liu N; Liu X; Ye N; Deng G; Luo C; Huang N; Sun C; Xu M; Zhou X; Deng H; Edwards CK; Chen X; Wang X; Cui K; Wei Y; Li J
    J Immunol; 2014 Feb; 192(4):1815-23. PubMed ID: 24453242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-10 levels are decreased in psoriatic lesional skin as compared to the psoriatic lesion-free and normal skin suction blister fluids.
    Mussi A; Bonifati C; Carducci M; Viola M; Tomaselli R; Sacerdoti G; Fazio M; Ameglio F
    J Biol Regul Homeost Agents; 1994; 8(4):117-20. PubMed ID: 7660853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
    Wei L; Debets R; Hegmans JJ; Benner R; Prens EP
    J Pathol; 1999 Feb; 187(3):358-64. PubMed ID: 10398092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human psoriatic skin in organ culture: comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor.
    Varani J; Kang S; Stoll S; Elder JT
    Pathobiology; 1998; 66(6):253-9. PubMed ID: 9769471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ expression of messenger RNA of interleukin-1 and interleukin-6 in psoriasis: interleukin-6 involved in formation of psoriatic lesions.
    Ohta Y; Katayama I; Funato T; Yokozeki H; Nishiyama S; Hirano T; Kishimoto T; Nishioka K
    Arch Dermatol Res; 1991; 283(6):351-6. PubMed ID: 1796815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intralesional and anatomopathologic features of psoriatic erythroderma].
    Samoud El Kissi S; Cherif Ben Hmida F; Ben Osman Dahri A; Boubacker MS; Hechmi-Louzir M
    Tunis Med; 2007 Jul; 85(7):573-5. PubMed ID: 18064989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers -- IL-12, IL-18 and IL-23.
    Piskin G; Tursen U; Sylva-Steenland RM; Bos JD; Teunissen MB
    Exp Dermatol; 2004 Dec; 13(12):764-72. PubMed ID: 15560760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol).
    Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I
    Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The level of prosaposin is decreased in the skin of patients with psoriasis vulgaris.
    Alessandrini F; Stachowitz S; Ring J; Behrendt H
    J Invest Dermatol; 2001 Mar; 116(3):394-400. PubMed ID: 11231313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of inflammatory cytokines in psoriatic skin.
    Yoshinaga Y; Higaki M; Terajima S; Ohkubo E; Nogita T; Miyasaka N; Kawashima M
    Arch Dermatol Res; 1995; 287(2):158-64. PubMed ID: 7763087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis.
    Kolbinger F; Loesche C; Valentin MA; Jiang X; Cheng Y; Jarvis P; Peters T; Calonder C; Bruin G; Polus F; Aigner B; Lee DM; Bodenlenz M; Sinner F; Pieber TR; Patel DD
    J Allergy Clin Immunol; 2017 Mar; 139(3):923-932.e8. PubMed ID: 27502297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
    Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
    Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
    Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
    J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoids.
    Gruaz D; Didierjean L; Grassi J; Frobert Y; Dayer JM; Saurat JH
    Dermatologica; 1989; 179(4):202-6. PubMed ID: 2695356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated interleukin-18 protein expression in early active and progressive plaque-type psoriatic lesions.
    Companjen A; van der Wel L; van der Fits L; Laman J; Prens E
    Eur Cytokine Netw; 2004; 15(3):210-6. PubMed ID: 15542445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.